News | July 11, 2007

GE, Abbott Labs Call Off $8.13 Billion Diagnostics Deal

A WALL STREET JOURNAL ONLINE NEWS ROUNDUP
July 11, 2007 - General Electric Co. and Abbott Laboratories announced they have terminated GE's $8.13 billion deal to buy Abbott's primary in-vitro and point-of-care diagnostics businesses.

In separate statements, the companies said they were unable to agree on "final terms and conditions" of the proposed deal. As a result, according to GE's statement, the companies "agreed it was in the best interests of both companies to mutually terminate their agreement and discussions."

The acquisition would have marked GE's entry into what is known as "in vitro" diagnostics, or laboratory testing, while Abbott would have shed a unit growing more slowly than other parts of its business. In vitro" diagnostics generally test blood or urine for diseases from cancer to HIV. Germany's Siemens AG, a GE rival in medical equipment, entered the market last year by paying $5.3 billion for Bayer AG's diagnostic unit.

The Abbott unit had sales of roughly $2.5 billion last year. GE would also have acquired Abbott's smaller point-of-care diagnostic group, which makes testing tools used at the bedside in hospitals, among other diagnostic tools.

Source: The Wall Street Journal Online

For more information: www.gehealthcare.com and www.abbott.com

Related Content

Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
Sun Nuclear Surpasses 100 Units Shipped Milestone With SRS MapCheck
News | Quality Assurance (QA) | October 26, 2018
Sun Nuclear Corp. announced the 100th shipment of its new SRS MapCheck for stereotactic radiosurgery (SRS). The...
myQA Daily is optimized for daily QA workflow efficiency.
News | Quality Assurance (QA) | October 18, 2018
myQA Daily from IBA Dosimetry enables fast as well as high-quality daily...
IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
FDA Approves New Tomosynthesis Quality Control Tests for ACR Digital Mammography QC Manual
News | Mammography | July 30, 2018
The U.S. Food and Drug Administration (FDA) recently approved the American College of Radiology’s (ACR’s) amendment to...
IBA Dosimetry Launches SmartScan Automated and Guided Beam Commissioning Solution
Technology | Quality Assurance (QA) | July 27, 2018
IBA (Ion Beam Applications S.A.) announced the market launch of its new SmartScan solution at the 60th annual American...
Designed to support a broad range of planning and delivery technologies, SunCheck 2.0 streamlines and standardizes workflows, allowing greater overall focus on patient safety.
Technology | Quality Assurance (QA) | April 27, 2018
Sun Nuclear Corp. released significant new functionality for its SunCheck Platform for patient and machine quality...
Barco Highlights Imaging Workflow Compliance at HIMSS18
News | Flat Panel Displays | February 21, 2018
Barco will showcase its full line of radiology and mammography display systems with online quality assurance (QA)...
Varian Acquires Mobius Medical Systems
News | Quality Assurance (QA) | February 06, 2018
February 6, 2018 – Varian announced it has acquired privately-held Mobius Medical Systems, a...